Aspivix Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series B2
  • (Upcoming)

  • Investors
  • 11

Aspivix General Information

Description

Developer of a suction cervical stabilizer designed to reduce pain and eliminate the risk of lesions and bleeding in women for gynecological purposes. The company's device offers suction-based cervical access devices that minimizes tissue trauma and bleeding during clinical interventions, improving cervical stabilization for reduced patient discomfort, enabling healthcare providers and women's health clinics to perform gynecological procedures with greater patient comfort and procedural consistency.

Contact Information

Website
www.aspivix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Route de la Corniche 8
  • Bureau 10
  • 1066 Epalinges
  • Switzerland
+41 079
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • Route de la Corniche 8
  • Bureau 10
  • 1066 Epalinges
  • Switzerland
+41 079

Aspivix Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aspivix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC (Series B2) Upcoming Generating Revenue
14. Equity Crowdfunding 15-Sep-2026 Completed Generating Revenue
13. Equity Crowdfunding 14-Mar-2025 Completed Generating Revenue
12. Later Stage VC (Series B1) 24-Dec-2024 Completed Generating Revenue
11. Debt - General 30-Jun-2024 Completed Generating Revenue
10. Later Stage VC (Series B) 31-Oct-2024 Completed Generating Revenue
9. Later Stage VC (Series A2) 17-Nov-2022 Completed Generating Revenue
8. Grant 01-Sep-2022 Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2021 $1.99M Completed Generating Revenue
6. Grant 01-Jan-2021 $250K $1.99M Completed Generating Revenue
To view Aspivix’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Aspivix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a suction cervical stabilizer designed to reduce pain and eliminate the risk of lesions and bleeding in wom
Therapeutic Devices
Epalinges, Switzerland
9 As of 2022

Irvine, CA
 

Hilton Head Island, SC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aspivix Competitors (8)

One of Aspivix’s 8 competitors is Masimo, a Formerly PE-Backed company based in Irvine, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Masimo Formerly PE-Backed Irvine, CA
Vygon (uk) Ltd. Corporation Hilton Head Island, SC
Boston Scientific Corporation Marlborough, MA
Mölnlycke Health Care Private Equity-Backed Mölndal, Sweden
Bioceptive Formerly VC-backed Baton Rouge, LA
You’re viewing 5 of 8 competitors. Get the full list »

Aspivix Patents

Aspivix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026146165-A1 Gynecological apparatus and kit Pending 30-Dec-2024
EP-4376737-A2 Handheld gynecological device, handle and rod member Active 29-Jul-2021
EP-4376737-B1 Handheld gynecological device, handle and rod member Active 29-Jul-2021
EP-4376737-C0 Handheld gynecological device, handle and rod member Active 29-Jul-2021
US-20240206913-A1 Handheld gynecological device, handle and rod member Pending 29-Jul-2021 A61B17/42
To view Aspivix’s complete patent history, request access »

Aspivix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aspivix Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hemex (Healthcare Services) VC-Backed Company Minority
Launchpad AI VC-Backed Company Minority
EUREKA Eurostars Government
Innosuisse Government Minority
Tech4Eva Accelerator/Incubator
You’re viewing 5 of 11 investors. Get the full list »

Aspivix FAQs

  • When was Aspivix founded?

    Aspivix was founded in 2015.

  • Where is Aspivix headquartered?

    Aspivix is headquartered in Epalinges, Switzerland.

  • What is the size of Aspivix?

    Aspivix has 9 total employees.

  • What industry is Aspivix in?

    Aspivix’s primary industry is Therapeutic Devices.

  • Is Aspivix a private or public company?

    Aspivix is a Private company.

  • What is Aspivix’s current revenue?

    The current revenue for Aspivix is .

  • How much funding has Aspivix raised over time?

    Aspivix has raised $21M.

  • Who are Aspivix’s investors?

    Hemex (Healthcare Services), Launchpad AI, EUREKA Eurostars, Innosuisse, and Tech4Eva are 5 of 11 investors who have invested in Aspivix.

  • Who are Aspivix’s competitors?

    Masimo, Vygon (uk) Ltd., Boston Scientific, Mölnlycke Health Care, and Bioceptive are some of the 8 competitors of Aspivix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process